Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Podoplanin expression in fibrous histiocytomas and cellular neurothekeomas.

Kaddu S, Leinweber B.

Am J Dermatopathol. 2009 Apr;31(2):137-9. doi: 10.1097/DAD.0b013e31819821c7.

PMID:
19318798
2.

Differential gene expression profiles of neurothekeomas and nerve sheath myxomas by microarray analysis.

Sheth S, Li X, Binder S, Dry SM.

Mod Pathol. 2011 Mar;24(3):343-54. doi: 10.1038/modpathol.2010.203. Epub 2011 Feb 4.

3.

High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.

Xu Y, Ogose A, Kawashima H, Hotta T, Ariizumi T, Li G, Umezu H, Endo N.

Oncol Rep. 2011 Mar;25(3):599-607. doi: 10.3892/or.2011.1141. Epub 2011 Jan 13.

PMID:
21234520
5.

Fibrous and fibrohistiocytic neoplasms: an update.

Clarke LE.

Dermatol Clin. 2012 Oct;30(4):643-56, vi. doi: 10.1016/j.det.2012.06.005. Epub 2012 Aug 11. Review.

PMID:
23021051
6.

Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.

Jokinen CH, Dadras SS, Goldblum JR, van de Rijn M, West RB, Rubin BP.

Am J Clin Pathol. 2008 Jun;129(6):886-93. doi: 10.1309/M7D5KTVYYE51XYQA.

PMID:
18480004
7.

Fibrohistiocytic tumors containing zebra body-like inclusions and fibripositors.

Pasquinelli G.

Ultrastruct Pathol. 2010 Dec;34(6):366-70. doi: 10.3109/01913123.2010.513079.

PMID:
21070169
8.
9.

Cellular neurothekeoma: detailed characterization in a series of 133 cases.

Hornick JL, Fletcher CD.

Am J Surg Pathol. 2007 Mar;31(3):329-40.

PMID:
17325474
10.

Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.

Yu H, Gibson JA, Pinkus GS, Hornick JL.

Am J Clin Pathol. 2007 Nov;128(5):776-82.

PMID:
17951199
11.

[Fibrohistiocytic skin tumors].

Hügel H.

J Dtsch Dermatol Ges. 2006 Jul;4(7):544-55. Review. German.

PMID:
16827912
12.
14.

High proliferative activity excludes dermatofibroma: report of the utility of MIB-1 in the differential diagnosis of selected fibrohistiocytic tumors.

Hanly AJ, Jordà M, Elgart GW, Badiavas E, Nassiri M, Nadji M.

Arch Pathol Lab Med. 2006 Jun;130(6):831-4.

PMID:
16740036
15.

Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.

West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T, Montgomery K, Nielsen TO, Rubin BP, Patel R, Goldblum JR, Brown PO, van de Rijn M.

Am J Surg Pathol. 2004 Aug;28(8):1063-9. Erratum in: Am J Surg Pathol. 2004 Oct;28(10):1400. Chih Long, Lui [corrected to Chih Long, Liu].

PMID:
15252314
16.

EMA positivity in epithelioid fibrous histiocytoma: a potential diagnostic pitfall.

Doyle LA, Fletcher CD.

J Cutan Pathol. 2011 Sep;38(9):697-703. doi: 10.1111/j.1600-0560.2011.01747.x. Epub 2011 Jul 14.

PMID:
21752057
17.

Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.

Liang H, Wu H, Giorgadze TA, Sariya D, Bellucci KS, Veerappan R, Liegl B, Acs G, Elenitsas R, Shukla S, Youngberg GA, Coogan PS, Pasha T, Zhang PJ, Xu X.

Am J Surg Pathol. 2007 Feb;31(2):304-10.

PMID:
17255777
19.

Podoplanin is a useful diagnostic marker for epithelioid hemangioendothelioma of the liver.

Fujii T, Zen Y, Sato Y, Sasaki M, Enomae M, Minato H, Masuda S, Uehara T, Katsuyama T, Nakanuma Y.

Mod Pathol. 2008 Feb;21(2):125-30. Epub 2007 Dec 14.

20.

Podoplanin is expressed in subsets of tumors of the central nervous system.

Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M.

Virchows Arch. 2006 Apr;448(4):493-9. Epub 2006 Jan 13.

PMID:
16411134

Supplemental Content

Support Center